[Clinical study on Shenning Mixture in treating IgA nephropathy].
To study the clinical therapeutic effect of Shenning Mixture (SNM) in treating IgA nephropathy. Patients were treated separately with SNM or prednisone by randomized grouping. The criteria, including clinical symptoms, signs, hematuria, albuminuria and immune globulin were observed. The total effective rate and the complete remission rate in the SNM group were 97.1% and 45.7% respectively, while in the control group, they were 37.1% and 8.6% respectively. Comparison of the two groups showed that the therapeutic effect in the former was better than that in the latter significantly, P < 0.01. The hematuria and albuminuria extenuated and serum IgA lowered more significantly in the SNM group than those in the control group (P < 0.05, P < 0.01). SNM has obvious therapeutic effect on the hematuria and albuminuria in treating IgA nephropathy.